Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09MPO
|
|||
| Drug Name |
HLD100
|
|||
| Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z; ICD-9: 314] | Phase 2 | [1] | |
| Company |
Highland Therapeutics Toronto, Canada Ironshore Pharmaceuticals Toronto, Canada
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.